Israeli Life Science Company IOPtima Raises $7.2M

November 28, 2015 • NEWS

BioLight Life Sciences Investments, which is the parent company of IOPtima, an Israeli life science company, signed a joint financing agreement with two Asia-based venture capital firms in order for them to invest $7.2 million into IOPtima. The new funding will be used to empower the global commercialization of its innovative IOPtimate system, which is used in the treatment of glaucoma. 


BioLight Life Sciences Investments, IOPtima
Pin It

Related Posts